Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have identified metabolites associated with type 2 diabetes and its complications, mainly obesity, retinopathy and dyslipidemia

Smokers are more likely to develop type 2 diabetes than non-smokers, according to Dr Ahmad al-Mulla, head of Hamad Medical Corporation’s (HMC) Tobacco Control Centre.

A new study by researchers in Qatar has shown that Type 2 diabetes can be reversed with dietary and lifestyle changes.

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) and the University of Iceland have identified a group of proteins involved in causing type 2 diabetes in humans.

A type 2 diabetes management programme developed by researchers from the UK’s University of Leicester and adapted for Qatar by a team of diabetes educators from Hamad Medical Corporation’s (HMC)

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) predict that type 2 diabetes prevalence in Qatar will soar from 17% in 2012 to at least 24% by 2050.

Research studies confirm that women who breastfeed their babies for six months or longer can reduce the risk of developing pre- and post-menopausal breast cancer, ovarian cancer, hypertension, and Type 2 diabetes.

Obesity, a major risk factor for Type 2 diabetes, is being treated at Hamad Medical Corporation’s (HMC) National Obesity Treatment Center through a unique bariatric and weight management service.

Patients with both type 2 diabetes and acute heart failure face a significantly lower risk of death but a higher risk of heart failure-related hospitalisation if they have had high systolic blood pressure on discharge from the hospital.